Imagion Biosystems is a biotech company aiming to make a difference to the lives of cancer patients, with groundbreaking imaging techniques being trialled in Australian hospitals.
CEO Bob Proulx joins Sean Aylmer from San Diego to talk about Imagion's work, and why they chose to list on the ASX.

ASX wipeout as oil surges; adult sites block Aussies; Gen Z rejects booze
22:08

Q+A: Oil shock rattles markets - should investors panic?
12:18

Afternoon Report | ASX tumbles
05:28